Back to Search
Start Over
MA17.04 Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC.
- Source :
- Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS124-S125, 2p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 19
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 180335033
- Full Text :
- https://doi.org/10.1016/j.jtho.2024.09.223